SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Publicaciones

Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis

Autores: Giacomo Tini, Edoardo Bertero, Alessio Signori, Maria Pia Sormani, Christoph Maack, Rudolf A. De Boer, Marco Canepa, Pietro Ameri
Publicado en: Journal of the American Heart Association, Edición 9, 2024, ISSN 2047-9980
Editor: Wiley-Blackwell
DOI: 10.1161/jaha.119.016309

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population

Autores: Valentina Bracun, Navin Suthahar, Canxia Shi, Sanne de Wit, Wouter C. Meijers, IJsbrand T. Klip, Rudolf A. de Boer, Joseph Pierre Aboumsallem
Publicado en: Frontiers in Cardiovascular Medicine, Edición 8, 2021, ISSN 2297-055X
Editor: Frontiers Media SA
DOI: 10.3389/fcvm.2021.753885

Circulating immune checkpoints predict heart failure outcomes

Autores: Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. de Boer, Wouter C. Meijers
Publicado en: ESC Heart Failure, Edición 10, 2025, Página(s) 2330-2337, ISSN 2055-5822
Editor: Wiley
DOI: 10.1002/ehf2.14304

Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial

Autores: S.N. Voorrips, E.M. BOORSMA, J.C. BEUSEKAMP, R.A. DE-BOER, M.A. CONNELLY, R.P.F. DULLAART, P. VAN-DER-MEER, D.J. VAN-VELDHUISEN, A.A. VOORS, K. DAMMAN, B.D. WESTENBRINK
Publicado en: Journal of Cardiac Failure, Edición 29, 2024, Página(s) 33-41, ISSN 1071-9164
Editor: Churchill Livingstone
DOI: 10.1016/j.cardfail.2022.09.009

Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence

Autores: Valentina Bracun, Bart van Essen, Adriaan A. Voors, Dirk J. van Veldhuisen, Kenneth Dickstein, Faiez Zannad, Marco Metra, Stefan Anker, Nilesh J. Samani, Piotr Ponikowski, Gerasimos Filippatos, John G.F. Cleland, Chim C. Lang, Leong L. Ng, Canxia Shi, Sanne de Wit, Joseph Pierre Aboumsallem, Wouter C. Meijers, IJsbrand T. Klip, Peter van der Meer, Rudolf A. de Boer
Publicado en: ESC Heart Failure, Edición 9, 2025, Página(s) 4167-4176, ISSN 2055-5822
Editor: Wiley
DOI: 10.1002/ehf2.14120

Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice

Autores: Sanne de Wit, Lotte Geerlings, Canxia Shi, Just Dronkers, Elisabeth M Schouten, Gillian Blancke, Vanessa Andries, Tess Yntema, Wouter C Meijers, Debby P Y Koonen, Lars Vereecke, Herman H W Silljé, Joseph-Pierre Aboumsallem, Rudolf A de Boer
Publicado en: Cardiovascular Research, Edición 120, 2024, Página(s) 612-622, ISSN 0008-6363
Editor: Elsevier BV
DOI: 10.1093/cvr/cvae038

Tumour biomarkers: association with heart failure outcomes

Autores: C. Shi, H. H. van der Wal, H. H. W. Silljé, M. M. Dokter, F. van den Berg, L. Huizinga, M. Vriesema, J. Post, S. D. Anker, J. G. Cleland, L. L. Ng, N. J. Samani, K. Dickstein, F. Zannad, C. C. Lang, P. L. van Haelst, J. A. Gietema, M. Metra, P. Ameri, M. Canepa, D. J. van Veldhuisen, A. A. Voors, R. A. de Boer
Publicado en: Journal of Internal Medicine, Edición 288, 2023, Página(s) 207-218, ISSN 0954-6820
Editor: Blackwell Publishing Inc.
DOI: 10.1111/joim.13053

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND

Autores: Navin Suthahar, Laura M. G. Meems, Coenraad Withaar, Thomas M. Gorter, Lyanne M. Kieneker, Ron T. Gansevoort, Stephan J. L. Bakker, Dirk J. van Veldhuisen, Rudolf A. de Boer
Publicado en: Scientific Reports, Edición 12, 2022, ISSN 2045-2322
Editor: Nature Publishing Group
DOI: 10.1038/s41598-021-02409-6

Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart

Autores: Carlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, Yuri D’Alessandra, Michele Russo, Daniela Sorriento, Michele Ciccarelli, Bernadett Kiss, Luc Bertrand, Dana Dawson, Ines Falcao-Pires, Mauro Giacca, Nazha Hamdani, Wolfgang A Linke, Manuel Mayr, Jolanda van der Velden, Serena Zacchigna, Alessandra Ghigo, Emilio Hirsch, Alexander R Lyon, Anikó Görbe, Péter Ferdinandy, Rosalinda Madonna,
Publicado en: Cardiovascular Research, Edición 116, 2020, Página(s) 1820-1834, ISSN 0008-6363
Editor: Elsevier BV
DOI: 10.1093/cvr/cvaa222

Mediators of the association between albuminuria and incident cancer: the PREVEND study

Autores: Li Luo, Priya Vart, Lyanne M Kieneker, Bert van der Vegt, Stephan J L Bakker, Eke G Gruppen, Niek F Casteleijn, Rudolf A de Boer, Navin Suthahar, Geertruida H de Bock, Joseph Pierre Aboumsallem, Ron T Gansevoort
Publicado en: Clinical Kidney Journal, Edición 17, 2024, ISSN 2048-8505
Editor: Oxford University Press
DOI: 10.1093/ckj/sfad295

Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

Autores: Sanne de Wit, Claire Glen, Rudolf A de Boer, Ninian N Lang
Publicado en: Cardiovascular Research, Edición 118, 2023, Página(s) 3451-3466, ISSN 0008-6363
Editor: Elsevier BV
DOI: 10.1093/cvr/cvac132

Evaluation of renal cancer progression in a mouse model of heart failure

Autores: Canxia Shi, Joseph Pierre Aboumsallem, Sanne de Wit, Elisabeth Maria Schouten, Valentina Bracun, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer
Publicado en: Cancer Communications, Edición 41, 2023, Página(s) 796-799, ISSN 2523-3548
Editor: Wiley
DOI: 10.1002/cac2.12185

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (<scp>HFA</scp>), European Society of Cardiology (<scp>ESC</scp>)

Autores: Wouter C. Meijers, Antoni Bayes‐Genis, Alexandre Mebazaa, Johann Bauersachs, John G.F. Cleland, Andrew J.S. Coats, James L. Januzzi, Alan S. Maisel, Kenneth McDonald, Thomas Mueller, A. Mark Richards, Petar Seferovic, Christian Mueller, Rudolf A. de Boer
Publicado en: European Journal of Heart Failure, Edición 23, 2023, Página(s) 1610-1632, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2346

Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy

Autores: Niels Grote Beverborg, Daniela Später, Ralph Knöll, Alejandro Hidalgo, Steve T. Yeh, Zaher Elbeck, Herman H. W. Silljé, Tim R. Eijgenraam, Humam Siga, Magdalena Zurek, Malin Palmér, Susanne Pehrsson, Tamsin Albery, Nils Bomer, Martijn F. Hoes, Cornelis J. Boogerd, Michael Frisk, Eva van Rooij, Sagar Damle, William E. Louch, Qing-Dong Wang, Regina Fritsche-Danielson, Kenneth R. Chien, Kenny M.
Publicado en: Nature Communications, Edición 12, 2022, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-021-25439-0

Autores: Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, Rudolf A. de Boer
Publicado en: European Journal of Heart Failure, Edición 22, 2023, Página(s) 775-788, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.1771

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction

Autores: Coenraad Withaar, Laura M G Meems, George Markousis-Mavrogenis, Cornelis J Boogerd, Herman H W Silljé, Elisabeth M Schouten, Martin M Dokter, Adriaan A Voors, B Daan Westenbrink, Carolyn S P Lam, Rudolf A de Boer
Publicado en: Cardiovascular Research, Edición 117, 2022, Página(s) 2108-2124, ISSN 0008-6363
Editor: Elsevier BV
DOI: 10.1093/cvr/cvaa256

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling

Autores: Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Harmen G. Booij, Silke U. Oberdorf-Maass, Martin M. Dokter, Anouk H. G. Wolters, Ben N. G. Giepmans, Wiek H. van Gilst, Joan H. Brown, Rudolf A. de Boer, Herman H. W. Silljé, B. Daan Westenbrink
Publicado en: Scientific Reports, Edición 13, 2023, ISSN 2045-2322
Editor: Nature Publishing Group
DOI: 10.1038/s41598-023-30514-1

Comorbidities complicating heart failure: changes over the last 15 years

Autores: Elles M. Screever, Martje H. L. van der Wal, Dirk J. van Veldhuisen, Tiny Jaarsma, Astrid Koops, Kuna S. van Dijk, Janke Warink-Riemersma, Jenifer E. Coster, B. Daan Westenbrink, Peter van der Meer, Rudolf A. de Boer, Wouter C. Meijers
Publicado en: Clinical Research in Cardiology, Edición 112, 2023, Página(s) 123-133, ISSN 1861-0684
Editor: Steinkopff
DOI: 10.1007/s00392-022-02076-1

Divergent effects of myostatin inhibition on cardiac and skeletal muscles in a mouse model of pressure overload

Autores: Canxia Shi, Sietske N. Zijlstra, Sanne de Wit, Wouter C. Meijers, Joseph Pierre Aboumsallem, Herman H. W. Silljé, Rudolf A. de Boer
Publicado en: American Journal of Physiology-Heart and Circulatory Physiology, Edición 325, 2023, Página(s) H195-H201, ISSN 0363-6135
Editor: American Physiological Society
DOI: 10.1152/ajpheart.00223.2023

Pectins from various sources inhibit galectin-3-related cardiac fibrosis

Autores: Carolin Pozder geb. Gehlken, A. Rogier van der Velde, Wouter C. Meijers, Herman H.W. Silljé, Pieter Muntendam, Martin M. Dokter, Wiek H. van Gilst, Henk A. Schols, Rudolf A. de Boer
Publicado en: Current Research in Translational Medicine, Edición 70, 2022, Página(s) 103321, ISSN 2452-3186
Editor: Elsevier BV
DOI: 10.1016/j.retram.2021.103321

Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms

Autores: Remco de Brouwer, Laura M.G. Meems, Tom E. Verstraelen, Belend Mahmoud, Virginnio Proost, Arthur A.M. Wilde, Laurens P. Bosman, Esmée van Drie, Paul A. van der Zwaag, J. Peter van Tintelen, Arjan C. Houweling, Maarten P. van den Berg, Rudolf A. de Boer
Publicado en: Heart Rhythm, Edición 19, 2023, Página(s) 427-434, ISSN 1547-5271
Editor: Elsevier BV
DOI: 10.1016/j.hrthm.2021.11.009

The role of immune checkpoints in cardiovascular disease

Autores: Laura I. Yousif, Anniek A. Tanja, Rudolf A. de Boer, Arco J. Teske, Wouter C. Meijers
Publicado en: Frontiers in Pharmacology, Edición 13, 2022, ISSN 1663-9812
Editor: Frontiers Media S.A.
DOI: 10.3389/fphar.2022.989431

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity

Autores: Stanley MH Yeung, Anne Nooteboom, Ewout J Hoorn, Joris I Rotmans, Liffert Vogt, Rudolf A de Boer, Ron T Gansevoort, Gerjan Navis, Stephan JL Bakker, Martin H De Borst
Publicado en: The American Journal of Clinical Nutrition, Edición 116, 2023, Página(s) 741-749, ISSN 0002-9165
Editor: American Society for Clinical Nutrition, Inc.
DOI: 10.1093/ajcn/nqac137

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the <scp>C</scp>ardio‐<scp>O</scp>ncology <scp>S</scp>tudy <scp>G</scp>roup of the <scp>H</scp>eart <scp>F</scp>ailure <scp>A</scp>ssociation of the <scp>E</scp>uropean <scp>S</scp>ociety of <scp>C</scp>ardiology in collaboration wi

Autores: Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yury Belenkov, Stuart D. Rosen, Zaza Iakobishv
Publicado en: European Journal of Heart Failure, Edición 22, 2023, Página(s) 1945-1960, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.1920

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

Autores: Rudolf A. de Boer, Stephane Heymans, Johannes Backs, Lucie Carrier, Andrew J.S. Coats, Stefanie Dimmeler, Thomas Eschenhagen, Gerasimos Filippatos, Lior Gepstein, Jean‐Sebastien Hulot, Ralph Knöll, Christian Kupatt, Wolfgang A. Linke, Christine E. Seidman, C. Gabriele Tocchetti, Jolanda van der Velden, Roddy Walsh, Petar M. Seferovic, Thomas Thum
Publicado en: European Journal of Heart Failure, Edición 24, 2023, Página(s) 406-420, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2414

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy

Autores: Tim R. Eijgenraam, Cornelis J. Boogerd, Nienke M. Stege, Vivian Oliveira Nunes Teixeira, Martin M. Dokter, Lukas E. Schmidt, Xiaoke Yin, Konstantinos Theofilatos, Manuel Mayr, Peter van der Meer, Eva van Rooij, Jolanda van der Velden, Herman H.W. Silljé, Rudolf A. de Boer
Publicado en: Circulation: Heart Failure, Edición 14, 2024, ISSN 1941-3297
Editor: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circheartfailure.121.008532

DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters

Autores: Nienke M. Stege, Tim R. Eijgenraam, Vivian Oliveira Nunes Teixeira, Anna M. Feringa, Elisabeth M. Schouten, Diederik W.D. Kuster, Jolanda van der Velden, Anouk H.G. Wolters, Ben N.G. Giepmans, Catherine A. Makarewich, Rhonda Bassel-Duby, Eric N. Olson, Rudolf A. de Boer, Herman H.W. Silljé
Publicado en: Circulation Research, Edición 133, 2024, Página(s) 1006-1021, ISSN 0009-7330
Editor: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circresaha.123.323304

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study

Autores: Victor W Zwartkruis, Bastiaan Geelhoed, Navin Suthahar, Stephan J L Bakker, Ron T Gansevoort, Isabelle C van Gelder, Rudolf A de Boer, Michiel Rienstra
Publicado en: Open Heart, Edición 8, 2024, Página(s) e001786, ISSN 2053-3624
Editor: BMJ
DOI: 10.1136/openhrt-2021-001786

Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF

Autores: George Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, João Pedro Ferreira, Stefan D Anker, John G Cleland, Kenneth Dickstein, Gerasimos Filippatos, Chim C Lang, Marco Metra, Nilesh J Samani, null null, Rudolf A de Boer, Dirk J van Veldhuisen, Adriaan A Voors, Peter van der Meer
Publicado en: Cardiovascular Research, Edición 118, 2022, Página(s) 1964-1977, ISSN 0008-6363
Editor: Elsevier BV
DOI: 10.1093/cvr/cvab235

Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial

Autores: Amy Groenewegen, Victor W Zwartkruis, Michiel Rienstra, Nicolaas P A Zuithoff, Monika Hollander, Hendrik Koffijberg, Martijn Oude Wolcherink, Maarten J Cramer, Yvonne T van der Schouw, Arno W Hoes, Frans H Rutten, Rudolf A de Boer
Publicado en: The Lancet Public Health, Edición 9, 2024, Página(s) e88-e99, ISSN 2468-2667
Editor: Elsevier BV
DOI: 10.1016/s2468-2667(23)00269-4

Proactive screening for symptoms: A simple method to improve early detection of unrecognized cardiovascular disease in primary care. Results from the Lifelines Cohort Study

Autores: Victor W. Zwartkruis, Amy Groenewegen, Frans H. Rutten, Monika Hollander, Arno W. Hoes, M. Yldau van der Ende, Pim van der Harst, Maarten Jan Cramer, Yvonne T. van der Schouw, Hendrik Koffijberg, Michiel Rienstra, Rudolf A. de Boer
Publicado en: Preventive Medicine, Edición 138, 2022, Página(s) 106143, ISSN 0091-7435
Editor: Academic Press
DOI: 10.1016/j.ypmed.2020.106143

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models

Autores: Coenraad Withaar, Carolyn S P Lam, Gabriele G Schiattarella, Rudolf A de Boer, Laura M G Meems
Publicado en: European Heart Journal, Edición 42, 2022, Página(s) 4420-4430, ISSN 0195-668X
Editor: Oxford University Press
DOI: 10.1093/eurheartj/ehab389

Sex differences in associations of comorbidities with incident cardiovascular disease: focus on absolute risk

Autores: Just Dronkers, Laura M G Meems, Dirk J van Veldhuisen, Sven Meyer, Lyanne M Kieneker, Ron T Gansevoort, Stephan J L Bakker, Michiel Rienstra, Rudolf A de Boer, Navin Suthahar
Publicado en: European Heart Journal Open, Edición 2, 2022, ISSN 2752-4191
Editor: Oxford University Press (OUP)
DOI: 10.1093/ehjopen/oeac017

Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies

Autores: Joseph Pierre Aboumsallem, Canxia Shi, Sanne De Wit, George Markousis-Mavrogenis, Valentina Bracun, Tim R. Eijgenraam, Martijn F. Hoes, Wouter C. Meijers, Elles M. Screever, Marloes E. Schouten, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. De Boer
Publicado en: Journal of Molecular and Cellular Cardiology, Edición 175, 2024, Página(s) 13-28, ISSN 0022-2828
Editor: Academic Press
DOI: 10.1016/j.yjmcc.2022.12.001

Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers

Autores: Canxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, Aniek O. de Graaf, Joop H. Jansen, Isabelle A. van Zeventer, Valentina Bracun, Sanne de Wit, Elles M. Screever, Pieter F. van den Berg, Wouter C. Meijers, Ron T. Gansevoort, Stephan J.L. Bakker, Pim van der Harst, Herman H.W. Silljé, Gerwin Huls, Rudolf A. de Boer
Publicado en: European Journal of Heart Failure, Edición 25, 2024, Página(s) 4-13, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2715

Troponins and natriuretic peptides to detect cardiotoxicity: useful biomarkers or paradise lost?

Autores: Valentina Bracun, Rudolf A. de Boer
Publicado en: European Journal of Heart Failure, Edición 22, 2023, Página(s) 362-365, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.1676

Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?

Autores: Kirsten T. Nijholt, Pablo I. Sánchez‐Aguilera, Suzanne N. Voorrips, Rudolf A. de Boer, B. Daan Westenbrink
Publicado en: European Journal of Heart Failure, Edición 24, 2023, Página(s) 287-298, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2407

Unbiased complexome profiling and global proteomics analysis reveals mitochondrial impairment and potential changes at the intercalated disk in presymptomatic R14Δ/+ mice hearts

Autores: Brian Foo, Hugo Amedei, Surmeet Kaur, Samir Jaawan, Angela Boshnakovska, Tanja Gall, Rudolf A. de Boer, Herman H. W. Silljé, Henning Urlaub, Peter Rehling, Christof Lenz, Stephan E. Lehnart
Publicado en: PLOS ONE, Edición 19, 2024, Página(s) e0311203, ISSN 1932-6203
Editor: Public Library of Science
DOI: 10.1371/journal.pone.0311203

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Autores: Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink
Publicado en: International Journal of Molecular Sciences, Edición 23, 2024, Página(s) 8631, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23158631

Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the <scp>Cardio‐Oncology Study Group</scp> of the <scp>Heart Failure Association</scp> and the <scp>Cardio‐Oncology Council of the European Society of Cardiology</scp>

Autores: Radek Pudil, Christian Mueller, Jelena Čelutkienė, Peter A. Henriksen, Dan Lenihan, Susan Dent, Ana Barac, Susanna Stanway, Javid Moslehi, Thomas M. Suter, Bonnie Ky, Martin Štěrba, Daniela Cardinale, Alain Cohen‐Solal, Carlo Gabriele Tocchetti, Dimitrios Farmakis, Jutta Bergler‐Klein, Markus S. Anker, Stephan Von Haehling, Yury Belenkov, Zaza Iakobishvili, Christoph Maack, Fortunato Ciard
Publicado en: European Journal of Heart Failure, Edición 22, 2023, Página(s) 1966-1983, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2017

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

Autores: Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H. W. Silljé
Publicado en: International Journal of Molecular Sciences, Edición 22, 2025, Página(s) 2955, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms22062955

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis

Autores: Sophie L van Veldhuisen, Thomas M Gorter, Gijs van Woerden, Rudolf A de Boer, Michiel Rienstra, Eric J Hazebroek, Dirk J van Veldhuisen
Publicado en: European Heart Journal, Edición 43, 2022, Página(s) 1955-1969, ISSN 0195-668X
Editor: Oxford University Press
DOI: 10.1093/eurheartj/ehac071

Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance

Autores: Carolin Pozder, Elles M. Screever, A. Rogier van der Velde, Herman H. Silljé, Janne Suwijn, Saskia de Rond, Marcus E. Kleber, Graciela Delgado, Jan Jacob Schuringa, Wiek H. van Gilst, Wouter C. Meijers, Winfried März, Rudolf A. de Boer
Publicado en: International Journal of Molecular Sciences, Edición 24, 2023, Página(s) 4415, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms24054415

Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care

Autores: L. M. G. Meems, D. J. van Veldhuisen, R. A. de Boer
Publicado en: Netherlands Heart Journal, Edición 28, 2022, Página(s) 31-38, ISSN 1568-5888
Editor: Mediselect B.V.
DOI: 10.1007/s12471-020-01453-7

Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

Autores: Valentina Bracun, Joseph Pierre Aboumsallem, Peter van der Meer, Rudolf A. de Boer
Publicado en: Current Oncology Reports, Edición 22, 2022, ISSN 1523-3790
Editor: Current Science Inc.
DOI: 10.1007/s11912-020-00930-x

Common risk factors for heart failure and cancer

Autores: Wouter C Meijers, Rudolf A de Boer
Publicado en: Cardiovascular Research, Edición 115, 2022, Página(s) 844-853, ISSN 0008-6363
Editor: Elsevier BV
DOI: 10.1093/cvr/cvz035

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C

Autores: Elles M. Screever, Jenny E. Kootstra-Ros, Joyce Doorn, Jellie A. Nieuwenhuis, Henk E. J. Meulenbelt, Wouter C. Meijers, Rudolf A. de Boer
Publicado en: Frontiers in Neurology, Edición 12, 2021, ISSN 1664-2295
Editor: Frontiers Research Foundation
DOI: 10.3389/fneur.2021.688246

Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

Autores: Arantxa González, A. Mark Richards, Rudolf A. de Boer, Thomas Thum, Henrike Arfsten, Martin Hülsmann, Inês Falcao‐Pires, Javier Díez, Roger S.Y. Foo, Mark Y. Chan, Alberto Aimo, Chukwuemeka G. Anene‐Nzelu, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D. Anker, Yuri Belenkov, Tuvia Ben Gal, Alain Cohen‐Solal, Michael Böhm, Ovidiu Chioncel, Victoria Delgado, Michele Emdin, Ewa A. Jankow
Publicado en: European Journal of Heart Failure, Edición 24, 2023, Página(s) 927-943, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2493

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction

Autores: Carolin Gehlken, Elles M. Screever, Navin Suthahar, Peter van der Meer, B. Daan Westenbrink, Jennifer E. Coster, Dirk J. Van Veldhuisen, Rudolf A. de Boer, Wouter C. Meijers
Publicado en: ESC Heart Failure, Edición 8, 2025, Página(s) 2458-2466, ISSN 2055-5822
Editor: Wiley
DOI: 10.1002/ehf2.13366

Cancer and heart disease: associations and relations

Autores: Rudolf A. de Boer, Wouter C. Meijers, Peter van der Meer, Dirk J. van Veldhuisen
Publicado en: European Journal of Heart Failure, Edición 21, 2023, Página(s) 1515-1525, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.1539

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease

Autores: Joseph Pierre Aboumsallem, Javid Moslehi, Rudolf A. de Boer
Publicado en: Journal of the American Heart Association, Edición 9, 2024, ISSN 2047-9980
Editor: Wiley-Blackwell
DOI: 10.1161/jaha.119.013754

Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass

Autores: Navin Suthahar, Victor Zwartkruis, Bastiaan Geelhoed, Coenraad Withaar, Laura M. G. Meems, Stephan J. L. Bakker, Ron T. Gansevoort, Dirk Jan van Veldhuisen, Michiel Rienstra, Rudolf A. de Boer
Publicado en: Obesity, Edición 32, 2024, Página(s) 603-611, ISSN 1930-7381
Editor: Wiley-Blackwell
DOI: 10.1002/oby.23953

Management of cardiac fibrosis is the largest unmet medical need in heart failure

Autores: Javier Díez, Rudolf A de Boer
Publicado en: Cardiovascular Research, Edición 118, 2022, Página(s) e20-e22, ISSN 0008-6363
Editor: Elsevier BV
DOI: 10.1093/cvr/cvab228

A new classification of cardio-oncology syndromes

Autores: Rudolf A. de Boer, Joseph Pierre Aboumsallem, Valentina Bracun, Douglas Leedy, Richard Cheng, Sahishnu Patel, David Rayan, Svetlana Zaharova, Jennifer Rymer, Jennifer M. Kwan, Joshua Levenson, Claudio Ronco, Paaladinesh Thavendiranathan, Sherry-Ann Brown
Publicado en: Cardio-Oncology, Edición 7, 2022, ISSN 2057-3804
Editor: Springer Science and Business Media LLC
DOI: 10.1186/s40959-021-00110-1

Reassessing the Mechanisms of PLN-R14del Cardiomyopathy

Autores: Nienke M. Stege, Rudolf A. de Boer, Catherine A. Makarewich, Peter van der Meer, Herman H.W. Silljé
Publicado en: JACC: Basic to Translational Science, Edición 9, 2024, Página(s) 1041-1052, ISSN 2452-302X
Editor: Elsevier BV
DOI: 10.1016/j.jacbts.2024.02.017

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study

Autores: Victor W Zwartkruis, Ekaterina Sharashova, Tom Wilsgaard, Rudolf A de Boer, Maja-Lisa Løchen, Michiel Rienstra
Publicado en: Open Heart, Edición 9, 2024, Página(s) e002086, ISSN 2053-3624
Editor: BMJ
DOI: 10.1136/openhrt-2022-002086

Being in Two Minds—The Challenge of Heart Failure with Preserved Ejection Fraction Diagnosis with a Single Biomarker

Autores: Navin Suthahar, Carsten Tschöpe, Rudolf A de Boer
Publicado en: Clinical Chemistry, Edición 67, 2021, Página(s) 46-49, ISSN 0009-9147
Editor: American Association for Clinical Chemistry, Inc.
DOI: 10.1093/clinchem/hvaa255

Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population

Autores: Navin Suthahar, Kan Wang, Victor W. Zwartkruis, Stephan J.L. Bakker, Silvio E. Inzucchi, Laura M.G. Meems, Tim R. Eijgenraam, Fariba Ahmadizar, Eric G. Sijbrands, Ron T. Gansevoort, Lyanne M. Kieneker, Dirk J. van Veldhuisen, Maryam Kavousi, Rudolf A. de Boer
Publicado en: European Journal of Internal Medicine, Edición 109, 2024, Página(s) 73-78, ISSN 0953-6205
Editor: Elsevier BV
DOI: 10.1016/j.ejim.2022.12.024

Preclinical Models of Cancer Therapy–Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association

Autores: Aarti Asnani, Javid J. Moslehi, Bishow B. Adhikari, Alan H. Baik, Andreas M. Beyer, Rudolf A. de Boer, Alessandra Ghigo, Isabella M. Grumbach, Salvia Jain, Han Zhu, null null
Publicado en: Circulation Research, Edición 129, 2024, ISSN 0009-7330
Editor: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/res.0000000000000473

Exploring Cardiac Fibrosis

Autores: Rudolf A. de Boer, Reza Ardehali
Publicado en: JACC: Basic to Translational Science, Edición 9, 2024, Página(s) 1023-1025, ISSN 2452-302X
Editor: Elsevier BV
DOI: 10.1016/j.jacbts.2024.06.006

Current understanding of fibrosis in genetic cardiomyopathies

Autores: Tim R. Eijgenraam, Herman H.W. Silljé, Rudolf A. de Boer
Publicado en: Trends in Cardiovascular Medicine, Edición 30, 2022, Página(s) 353-361, ISSN 1050-1738
Editor: Elsevier BV
DOI: 10.1016/j.tcm.2019.09.003

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is <scp>Dickkopf</scp>‐3 (<scp>DKK3</scp>) a possible candidate?

Autores: Arnold Piek, Navin Suthahar, Adriaan A. Voors, Rudolf A. de Boer, Herman H.W. Silljé
Publicado en: European Journal of Heart Failure, Edición 22, 2023, Página(s) 2065-2074, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.1988

Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors

Autores: Pieter F. van den Berg, Valentina Bracun, Michel Noordman, Peter van der Meer, Canxia Shi, Sjoukje F. Oosting, Joseph Pierre Aboumsallem, Sanne de Wit, Wouter C. Meijers, Mathilde Jalving, Michel van Kruchten, Rudolf A. de Boer
Publicado en: JACC: Advances, Edición 3, 2025, Página(s) 101375, ISSN 2772-963X
Editor: Elsevier BV
DOI: 10.1016/j.jacadv.2024.101375

Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure

Autores: Wouter Ouwerkerk, Joao P. Belo Pereira, Troy Maasland, Johanna E. Emmens, Sylwia M. Figarska, Jasper Tromp, Andrea L. Koekemoer, Christopher P. Nelson, Mintu Nath, Simon P.R. Romaine, John G.F. Cleland, Faiez Zannad, Dirk J. van Veldhuisen, Chim C. Lang, Piotr Ponikowski, Gerasimos Filippatos, Stefan Anker, Marco Metra, Kenneth Dickstein, Leong L. Ng, Rudolf A. de Boer, Natal van Riel, Max Nieuwdo
Publicado en: Journal of the American College of Cardiology, Edición 82, 2024, Página(s) 1921-1931, ISSN 0735-1097
Editor: Elsevier BV
DOI: 10.1016/j.jacc.2023.08.053

Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population

Autores: Leah B. Kosyakovsky, Rudolf A. de Boer, Jennifer E. Ho
Publicado en: Current Heart Failure Reports, Edición 21, 2024, Página(s) 591-603, ISSN 1546-9530
Editor: Current Science Inc.
DOI: 10.1007/s11897-024-00686-6

Relationship between body mass index, cardiovascular biomarkers and incident heart failure

Autores: Navin Suthahar, Laura M.G. Meems, Dion Groothof, Stephan J.L. Bakker, Ron T. Gansevoort, Dirk J. van Veldhuisen, Rudolf A. de Boer
Publicado en: European Journal of Heart Failure, Edición 23, 2023, Página(s) 396-402, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2102

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Autores: Remco de Brouwer, Wouter P te Rijdt, Edgar T Hoorntje, Ahmad Amin, Folkert W Asselbergs, Moniek G P J Cox, Jeroen F van der Heijden, Hans Hillege, Jacco C Karper, Belend Mahmoud, Peter van der Meer, Anton Oomen, Anneline S J M te Riele, Herman H W Silljé, Hanno L Tan, Jan Peter van Tintelen, Dirk J van Veldhuisen, Berend Daan Westenbrink, Ans C P Wiesfeld, Tineke P Willems, Paul A van der Zwaag,
Publicado en: European Heart Journal, Edición 44, 2023, Página(s) 4284-4287, ISSN 0195-668X
Editor: Oxford University Press
DOI: 10.1093/eurheartj/ehad292

Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years

Autores: Bart J van Essen, Johanna E Emmens, Jasper Tromp, Wouter Ouwerkerk, Marcelle D Smit, Christiane A Geluk, Lukas Baumhove, Navin Suthahar, Ron T Gansevoort, Stephan J L Bakker, Kevin Damman, Peter van der Meer, Rudolf A de Boer, Dirk J van Veldhuisen, Adriaan A Voors
Publicado en: European Heart Journal, Edición 46, 2025, Página(s) 1528-1536, ISSN 0195-668X
Editor: Oxford University Press
DOI: 10.1093/eurheartj/ehae868

Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

Autores: Anja Karlstaedt, Javid Moslehi, Rudolf A. de Boer
Publicado en: Nature Reviews Cardiology, Edición 19, 2022, Página(s) 414-425, ISSN 1759-5002
Editor: Nature Publishing Group
DOI: 10.1038/s41569-022-00698-6

High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men

Autores: Navin Suthahar, Laura M.G. Meems, Dirk J. van Veldhuisen, Joan E. Walter, Ron T. Gansevoort, Stephane Heymans, Blanche Schroen, Pim van der Harst, Jenny E. Kootstra-Ros, Vanessa van Empel, Christian Mueller, Stephan J.L. Bakker, Rudolf A. de Boer
Publicado en: Mayo Clinic Proceedings, Edición 95, 2022, Página(s) 1158-1168, ISSN 0025-6196
Editor: Mayo Medical Ventures
DOI: 10.1016/j.mayocp.2020.01.017

Distinct pathophysiological pathways in women and men with heart failure

Autores: Alice Ravera, Bernadet T. Santema, Rudolf A. de Boer, Stefan D. Anker, Nilesh J. Samani, Chim C. Lang, Leong Ng, John G.F. Cleland, Kenneth Dickstein, Carolyn S.P. Lam, Harriette G. C. Van Spall, Gerasimos Filippatos, Dirk J. van Veldhuisen, Marco Metra, Adriaan A. Voors, Iziah E. Sama
Publicado en: European Journal of Heart Failure, Edición 24, 2023, Página(s) 1532-1544, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2534

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

Autores: Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltán V Varga
Publicado en: European Heart Journal, Edición 45, 2024, Página(s) 1224-1240, ISSN 0195-668X
Editor: Oxford University Press
DOI: 10.1093/eurheartj/ehae105

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity

Autores: Bas M. van Dalen, Jie Fen Chin, Praveen A. Motiram, Anneke Hendrix, Mireille E. Emans, Jasper J. Brugts, B. Daan Westenbrink, Rudolf A. de Boer
Publicado en: Cardiovascular Diabetology, Edición 24, 2025, ISSN 1475-2840
Editor: BioMed Central
DOI: 10.1186/s12933-025-02612-z

Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction

Autores: A. Hagendorff, S. Stöbe, J. Kandels, R. de Boer, C. Tschöpe
Publicado en: Herz, Edición 47, 2022, Página(s) 293-300, ISSN 0340-9937
Editor: Urban und Vogel Medien und Medizin Verlagsgesellschaft mbH
DOI: 10.1007/s00059-022-05118-6

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Autores: Daan C H Ceelen, Valentina Bracun, Bart J van Essen, Adriaan A Voors, Rudolf A de Boer, Jozine M ter Maaten, Serge Masson, Peter Kastner, Chim C Lang, Navin Suthahar
Publicado en: Heart, Edición 111, 2025, Página(s) 172-179, ISSN 1355-6037
Editor: BMJ Publishing Group
DOI: 10.1136/heartjnl-2024-324486

Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms

Autores: Canxia Shi, Sanne de Wit, Emina Učambarlić, George Markousis-Mavrogenis, Elles Screever, Wouter Meijers, Rudolf de Boer, Joseph Aboumsallem
Publicado en: Cancers, Edición 15, 2025, Página(s) 729, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers15030729

A Kinase Interacting Protein 1 regulates mitochondrial protein levels in energy metabolism and promotes mitochondrial turnover after exercise

Autores: Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Belend Mahmoud, Albert Gerding, Justina C. Wolters, Anouk H. G. Wolters, Ben N. G. Giepmans, Herman H. W. Silljé, Rudolf A. de Boer, Barbara M. Bakker, B. Daan Westenbrink
Publicado en: Scientific Reports, Edición 13, 2023, ISSN 2045-2322
Editor: Nature Publishing Group
DOI: 10.1038/s41598-023-45961-z

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population

Autores: Arnold Piek, Leonie Smit, Navin Suthahar, Stephan J. L. Bakker, Rudolf A. de Boer, Herman H. W. Silljé
Publicado en: Scientific Reports, Edición 11, 2022, ISSN 2045-2322
Editor: Nature Publishing Group
DOI: 10.1038/s41598-021-88107-9

Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities

Autores: Laura I. Yousif, Elles M. Screever, Daniëlle Versluis, Joseph Pierre Aboumsallem, Stefan Nierkens, Olivier C. Manintveld, Rudolf A. de Boer, Wouter C. Meijers
Publicado en: Current Oncology Reports, Edición 25, 2023, Página(s) 753-763, ISSN 1523-3790
Editor: Current Science Inc.
DOI: 10.1007/s11912-023-01414-4

Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation

Autores: Tim R. Eijgenraam, Nienke M. Stege, Vivian Oliveira Nunes Teixeira, Remco de Brouwer, Elisabeth M. Schouten, Niels Grote Beverborg, Liu Sun, Daniela Später, Ralph Knöll, Kenny M. Hansson, Carl Amilon, David Janzén, Steve T. Yeh, Adam E. Mullick, Peter van der Meer, Rudolf A. de Boer, Herman H. W. Silljé
Publicado en: International Journal of Molecular Sciences, Edición 23, 2024, Página(s) 2427, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23052427

Relative fat mass and prediction of incident atrial fibrillation, heart failure and coronary artery disease in the general population

Autores: Victor W. Zwartkruis, Navin Suthahar, Demy L. Idema, Belend Mahmoud, Colinda van Deutekom, Frans H. Rutten, Yvonne T. van der Schouw, Michiel Rienstra, Rudolf A. de Boer
Publicado en: International Journal of Obesity, Edición 47, 2023, Página(s) 1256-1262, ISSN 0307-0565
Editor: Nature Publishing Group
DOI: 10.1038/s41366-023-01380-8

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure

Autores: Pieter F. van den Berg, Joseph Pierre Aboumsallem, Elles M. Screever, Canxia Shi, Sanne de Wit, Valentina Bracun, Laura I. Yousif, Lotte Geerlings, Dongyu Wang, Jennifer E. Ho, Stephan J.L. Bakker, Bert van der Vegt, Herman H.W. Silljé, Rudolf A. de Boer, Wouter C. Meijers
Publicado en: JACC: CardioOncology, Edición 5, 2023, Página(s) 445-453, ISSN 2666-0873
Editor: Elsevier BV
DOI: 10.1016/j.jaccao.2023.03.015

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy

Autores: Rafik Tadros, Sean L. Zheng, Christopher Grace, Paloma Jordà, Catherine Francis, Dominique M. West, Sean J. Jurgens, Kate L. Thomson, Andrew R. Harper, Elizabeth Ormondroyd, Xiao Xu, Pantazis I. Theotokis, Rachel J. Buchan, Kathryn A. McGurk, Francesco Mazzarotto, Beatrice Boschi, Elisabetta Pelo, Michael Lee, Michela Noseda, Amanda Varnava, Alexa M. C. Vermeer, Roddy Walsh, Ahmad S. Amin, Marjon
Publicado en: Nature Genetics, Edición 57, 2025, Página(s) 530-538, ISSN 1061-4036
Editor: Nature Publishing Group
DOI: 10.1038/s41588-025-02087-4

An increase in albuminuria is associated with a higher incidence of malignancies

Autores: Li Luo, Lyanne M Kieneker, Yuanhang Yang, Roemer J Janse, Alessandro Bosi, Rudolf A de Boer, Priya Vart, Juan-Jesus Carrero, Ron T Gansevoort
Publicado en: Clinical Kidney Journal, Edición 17, 2024, ISSN 2048-8505
Editor: Oxford University Press
DOI: 10.1093/ckj/sfae009

Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure

Autores: Daan Ceelen, Adriaan A. Voors, Jasper Tromp, Dirk J. van Veldhuisen, Kenneth Dickstein, Rudolf A. de Boer, Chim C. Lang, Stefan D. Anker, Leong L. Ng, Marco Metra, Piotr Ponikowski, Sylwia M. Figarska
Publicado en: European Journal of Heart Failure, Edición 24, 2023, Página(s) 308-320, ISSN 1388-9842
Editor: Elsevier BV
DOI: 10.1002/ejhf.2424

Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHF

Autores: P. F. van den Berg, L. I. Yousif, G. Markousis-Mavrogenis, C. Shi, V. Bracun, J. Tromp, S. de Wit, Y. Appels, E. M. Screever, J. P. Aboumsallem, W. Ouwerkerk, D. J. van Veldhuisen, H. H. W. Silljé, A. A. Voors, R. A. de Boer, Wouter C. Meijers
Publicado en: Cardio-Oncology, Edición 10, 2024, ISSN 2057-3804
Editor: Springer Science and Business Media LLC
DOI: 10.1186/s40959-024-00246-w

Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology

Autores: Andrew J S Coats, Stephane Heymans, Dimitrios Farmakis, Stefan D Anker, Johannes Backs, Johann Bauersachs, Rudolf A de Boer, Jelena Čelutkienė, John G F Cleland, Dobromir Dobrev, Isabelle C van Gelder, Stephan von Haehling, Gerhard Hindricks, Ewa Jankowska, Dipak Kotecha, Linda W van Laake, Mitja Lainscak, Lars H Lund, Ida Gjervold Lunde, Alexander R Lyon, Aristomenis Manouras, Davor Miličić,
Publicado en: European Heart Journal, Edición 43, 2022, Página(s) 863-867, ISSN 0195-668X
Editor: Oxford University Press
DOI: 10.1093/eurheartj/ehab834

The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

Autores: Tim R. Eijgenraam, Bastiaan J. Boukens, Cornelis J. Boogerd, E. Marloes Schouten, Cees W. A. van de Kolk, Nienke M. Stege, Wouter P. te Rijdt, Edgar T. Hoorntje, Paul A. van der Zwaag, Eva van Rooij, J. Peter van Tintelen, Maarten P. van den Berg, Peter van der Meer, Jolanda van der Velden, Herman H. W. Silljé, Rudolf A. de Boer
Publicado en: Scientific Reports, Edición 10, 2022, ISSN 2045-2322
Editor: Nature Publishing Group
DOI: 10.1038/s41598-020-66656-9

Buscando datos de OpenAIRE...

Publicaciones

Compartir esta página Compartir esta página en las redes sociales

Descargar Descargar el contenido de la página